Valuation : West Pharmaceutical Services, Inc.

Market Cap 24.36B 20.99B 19.68B 17.96B 33.84B 2,328B 33.95B 233B 91.09B 1,175B 91.45B 89.46B 3,896B P/E 2026 *
40.4x
P/E 2027 * 35.1x
Enterprise Value 23.85B 20.55B 19.27B 17.59B 33.14B 2,280B 33.25B 229B 89.21B 1,151B 89.56B 87.61B 3,816B EV / Sales 2026 *
7.07x
EV / Sales 2027 * 6.5x
Free-Float
92.89%
Yield 2026 *
0.26%
Yield 2027 * 0.28%
1 week-1.96%
Current month+0.47%
1 month+2.06%
3 months+10.76%
6 months+38.07%
Current year+28.39%
1 week 292.3
Extreme 292.3
306.6
1 month 289.05
Extreme 289.05
308.75
3 years 168.65
Extreme 168.65
386.1
5 years 168.65
Extreme 168.65
418.6
Manager TitleAgeSince
Chief Executive Officer 56 24/04/2015
Director of Finance/CFO 57 04/08/2025
Chief Tech/Sci/R&D Officer - 01/08/2025
Director TitleAgeSince
Director/Board Member 65 01/02/2011
Director/Board Member 69 07/03/2011
Director/Board Member 56 12/02/2012
Change 5-day change 1-year change 3-year change Capi.($)
-1.78%-1.96%+40.58%-18.31% 24.36B
+0.81%-3.45%-14.27%+9.56% 193B
+1.28%-2.41%-0.94%+11.93% 115B
+0.08%+1.22%+11.05%+78.46% 61.3B
-0.25%-3.31%+27.04%+55.45% 51.37B
+0.95%-1.08%-0.70%-32.54% 51.24B
+1.23%-2.05%+20.47%-8.90% 33.69B
+1.37%+2.80% - - 30.4B
-2.05%-4.11%+37.94%-16.06% 24.36B
-0.82%-1.46%-5.14%+22.13% 23.7B
Average +0.30%-0.18%+12.89%+11.30% 64.92B
Weighted average by Cap. +0.60%-1.05%+2.85%+14.87%

Financials

2026 *2027 *
Net sales 3.37B 2.91B 2.73B 2.49B 4.69B 323B 4.7B 32.35B 12.62B 163B 12.67B 12.39B 540B 3.59B 3.09B 2.9B 2.65B 4.98B 343B 5B 34.38B 13.42B 173B 13.47B 13.17B 574B
Net income 615M 530M 497M 453M 854M 58.73B 857M 5.89B 2.3B 29.65B 2.31B 2.26B 98.31B 701M 604M 567M 517M 974M 67.02B 977M 6.72B 2.62B 33.83B 2.63B 2.58B 112B
Net Debt -503M -434M -407M -371M -699M -48.1B -701M -4.82B -1.88B -24.28B -1.89B -1.85B -80.51B -1.04B -895M -840M -766M -1.44B -99.31B -1.45B -9.96B -3.89B -50.13B -3.9B -3.82B -166B
Logo West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and administration of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by group of products as follows: - proprietary products (81.1%); - contract-manufactured products (18.9%). At the end of 2025, the group had 25 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (43.2%), Germany (12.4%), Ireland (10.8%), France (7.4%), Europe (14.7%) and other (11.5%).
Employees
-
Date Price Change
28/08/26 292.30 -1.78%
27/08/26 €297.60 -1.11%
26/08/26 €300.95 +0.67%
25/08/26 €298.95 -1.19%
24/08/26 €302.55 +0.03%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
346.09USD
Average target price
404.73USD
Spread / Average Target
+16.94%

Quarterly revenue - Rate of surprise